(XT) iShares Exponential - Ratings and Ratios
Tech Stocks, Robotics, Cloud, Biotech, CyberSecurity
Description: XT iShares Exponential
The iShares Exponential Technologies ETF (NASDAQ:XT) is an exchange-traded fund that tracks a subset of the Morningstar Global Markets Index, investing at least 80% of its assets in component securities or economically identical investments. This suggests a diversified portfolio with a focus on companies driving technological advancements.
To evaluate the funds performance, we can look beyond the provided technical and fundamental data. Key Performance Indicators (KPIs) such as the funds expense ratio, tracking error, and holdings diversification can offer insights into its operational efficiency and investment strategy. A lower expense ratio indicates lower costs for investors, while a lower tracking error suggests the fund more closely follows its underlying index.
Given the funds focus on exponential technologies, its likely to have a significant allocation to sectors such as technology, healthcare, and possibly industrials, where innovation is rapid. Investors should consider the funds sectoral weights, top holdings, and the overall growth prospects of its constituent companies. The funds AUM of $3.5 billion indicates a reasonable level of liquidity, but investors should also assess the liquidity of the underlying holdings.
To make an informed investment decision, one should analyze the funds historical performance, including its returns relative to the broader market and its benchmark index, as well as its risk-adjusted performance metrics such as the Sharpe ratio. Additionally, understanding the funds rebalancing strategy and tax efficiency can provide a more comprehensive view of its potential to meet investment objectives.
XT ETF Overview
Market Cap in USD | 3,586m |
Category | Miscellaneous Sector |
TER | 0.46% |
IPO / Inception | 2015-03-19 |
XT ETF Ratings
Growth Rating | 59.0% |
Fundamental | - |
Dividend Rating | 22.4% |
Return 12m vs S&P 500 | 0.84% |
Analyst Rating | - |
XT Dividends
Dividend Yield 12m | 0.68% |
Yield on Cost 5y | 0.94% |
Annual Growth 5y | -2.29% |
Payout Consistency | 89.0% |
Payout Ratio | % |
XT Growth Ratios
Growth Correlation 3m | 85.2% |
Growth Correlation 12m | 61.1% |
Growth Correlation 5y | 25.6% |
CAGR 5y | 13.82% |
CAGR/Max DD 3y | 0.63 |
CAGR/Mean DD 3y | 3.73 |
Sharpe Ratio 12m | 1.00 |
Alpha | 2.26 |
Beta | 0.894 |
Volatility | 14.82% |
Current Volume | 49.1k |
Average Volume 20d | 65k |
Stop Loss | 67.7 (-3.1%) |
Signal | 0.46 |
What is the price of XT shares?
Over the past week, the price has changed by +0.27%, over one month by +4.80%, over three months by +9.72% and over the past year by +19.89%.
Is iShares Exponential a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XT is around 65.39 USD . This means that XT is currently overvalued and has a potential downside of -6.44%.
Is XT a buy, sell or hold?
What are the forecasts/targets for the XT price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 73.4 | 5.1% |
Last update: 2025-09-12 04:48
XT Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 1.27
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.59b USD (3.59b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 3.59b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.59b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(3.59b)/V(0.0) * Re(9.31%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for XT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle